189 related articles for article (PubMed ID: 26279283)
1. Differences in omega-3 and omega-6 polyunsaturated fatty acid consumption in people at ultra-high risk of psychosis, first-episode schizophrenia, and in healthy controls.
Pawełczyk T; Trafalska E; Pawełczyk A; Kotlicka-Antczak M
Early Interv Psychiatry; 2017 Dec; 11(6):498-508. PubMed ID: 26279283
[TBL] [Abstract][Full Text] [Related]
2. The association between polyunsaturated fatty acid consumption and the transition to psychosis in ultra-high risk individuals.
Pawełczyk T; Trafalska E; Kotlicka-Antczak M; Pawełczyk A
Prostaglandins Leukot Essent Fatty Acids; 2016 May; 108():30-7. PubMed ID: 27154362
[TBL] [Abstract][Full Text] [Related]
3. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
[TBL] [Abstract][Full Text] [Related]
4. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
[TBL] [Abstract][Full Text] [Related]
6. Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
Smesny S; Milleit B; Schaefer MR; Hesse J; Schlögelhofer M; Langbein K; Hipler UC; Berger M; Cotter DR; Sauer H; McGorry PD; Amminger GP
Schizophr Res; 2017 Oct; 188():110-117. PubMed ID: 28126360
[TBL] [Abstract][Full Text] [Related]
7. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte polyunsaturated fatty acid levels in young people at ultra-high risk for psychotic disorder and healthy adolescent controls.
Rice SM; Schäfer MR; Klier C; Mossaheb N; Vijayakumar N; Amminger GP
Psychiatry Res; 2015 Jul; 228(1):174-6. PubMed ID: 25979466
[TBL] [Abstract][Full Text] [Related]
9. Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people.
Alqarni A; Mitchell TW; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Amminger GP; Meyer BJ
Schizophr Res; 2020 Dec; 226():44-51. PubMed ID: 31301881
[TBL] [Abstract][Full Text] [Related]
10. NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.
Markulev C; McGorry PD; Nelson B; Yuen HP; Schaefer M; Yung AR; Thompson A; Berger G; Mossaheb N; Schlögelhofer M; Smesny S; de Haan L; Riecher-Rössler A; Nordentoft M; Chen EYH; Verma S; Hickie I; Amminger GP
Early Interv Psychiatry; 2017 Oct; 11(5):418-428. PubMed ID: 26279065
[TBL] [Abstract][Full Text] [Related]
11. Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study.
Berger ME; Smesny S; Kim SW; Davey CG; Rice S; Sarnyai Z; Schlögelhofer M; Schäfer MR; Berk M; McGorry PD; Amminger GP
Transl Psychiatry; 2017 Aug; 7(8):e1220. PubMed ID: 28850110
[TBL] [Abstract][Full Text] [Related]
12. Salivary cortisol in early psychosis: New findings and meta-analysis.
Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.
Smesny S; Milleit B; Hipler UC; Milleit C; Schäfer MR; Klier CM; Holub M; Holzer I; Berger GE; Otto M; Nenadic I; Berk M; McGorry PD; Sauer H; Amminger GP
Mol Psychiatry; 2014 Mar; 19(3):317-24. PubMed ID: 23478748
[TBL] [Abstract][Full Text] [Related]
14. Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.
Amminger GP; Mechelli A; Rice S; Kim SW; Klier CM; McNamara RK; Berk M; McGorry PD; Schäfer MR
Transl Psychiatry; 2015 Jan; 5(1):e495. PubMed ID: 25585167
[TBL] [Abstract][Full Text] [Related]
15. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms.
Hsu MC; Huang YS; Ouyang WC
Lipids Health Dis; 2020 Jul; 19(1):159. PubMed ID: 32620164
[TBL] [Abstract][Full Text] [Related]
17. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
[TBL] [Abstract][Full Text] [Related]
18. Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis.
Lavoie S; Schäfer MR; Whitford TJ; Benninger F; Feucht M; Klier CM; Yuen HP; Pantelis C; McGorry PD; Amminger GP
Schizophr Res; 2012 Jul; 138(2-3):206-11. PubMed ID: 22520856
[TBL] [Abstract][Full Text] [Related]
19. Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.
Hou CL; Xiang YT; Wang ZL; Everall I; Tang Y; Yang C; Xu MZ; Correll CU; Jia FJ
Schizophr Res; 2016 Jul; 174(1-3):71-76. PubMed ID: 27197904
[TBL] [Abstract][Full Text] [Related]
20. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
